Drugs / WN/DEN4-3'delta30
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00094718 | Feb → Apr 2005 | West-Nile encephalitis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WN/DEN4-3'delta30 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00094718 ↗ |
| Modality | Vaccine | “Live attenuated WN/DEN4-3'delta30 vaccine” NCT00094718 ↗ |
| Route | Subcutaneous | “subcutaneous vaccination” NCT00094718 ↗ |